Effects of microplastic and engineered nanomaterials on inflammatory bowel disease: A review

被引:13
|
作者
Zhao Y. [1 ]
Liu S. [1 ]
Xu H. [1 ]
机构
[1] State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang
基金
中国国家自然科学基金;
关键词
Engineered nanomaterials; Inflammatory bowel disease; Intestinal inflammation; Microplastic; Molecular mechanism;
D O I
10.1016/j.chemosphere.2023.138486
中图分类号
学科分类号
摘要
Many microplastics and engineered nanomaterials (ENMs) exist in the daily environment. The intestinal impact of these exogenous fine particles on inflammatory bowel disease (IBD) people may be unpredictable. In this paper, we reviewed the recent progress in the effect of microplastics and ENMs on IBD individuals. We also compared and summarized the various roles of microplastics and ENMs in healthy and IBD bodies, including factors such as particle size, particle properties, intestinal microenvironment, interaction with the intestinal barrier, and molecular mechanism. Our literature review showed that microplastics could be accomplices in the development of IBD and could cause severe intestinal inflammation. Moreover, ENMs could elicit diverse exposure outcomes in healthy and IBD bodies. Silicon dioxide nanoparticles (SiO2 NPs), titanium dioxide nanoparticles (TiO2 NPs), and graphene oxide (GO) displayed slight to adverse effects that turned into apparent adverse effects, while zinc oxide nanoparticles (ZnO NPs) and silver nanoparticles (Ag NPs) showed a toxic effect that became therapeutic. A deeper understanding of the impact of microplastics and ENMs on the high-risk group was needed, and we proposed several insights into the research priorities and directions. © 2023 Elsevier Ltd
引用
收藏
相关论文
共 50 条
  • [41] Dermatologic Manifestations of Inflammatory Bowel Disease: A Review
    Keyal, Uma
    Liu, Yeqiang
    Bhatta, Anil Kumar
    DISCOVERY MEDICINE, 2018, 25 (139) : 225 - 233
  • [42] CORTICOSTEROIDS IN INFLAMMATORY BOWEL-DISEASE - A REVIEW
    ROUTES, J
    CLAMAN, HN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (05) : 529 - 535
  • [43] Probiotics in inflammatory bowel disease: a critical review
    Tamboli, CP
    Caucheteux, C
    Cortot, A
    Colombel, JF
    Desreumaux, P
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (05) : 805 - 820
  • [44] Antidepressants in Inflammatory Bowel Disease: A Systematic Review
    Macer, Benjamin J. D.
    Prady, Stephanie L.
    Mikocka-Walus, Antonina
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (04) : 534 - 550
  • [45] Review article: cytomegalovirus and inflammatory bowel disease
    Sager, K.
    Alam, S.
    Bond, A.
    Chinnappan, L.
    Probert, C. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 725 - 733
  • [46] Inflammatory bowel disease in Asia: A systematic review
    Prideaux, Lani
    Kamm, Michael A.
    De Cruz, Peter P.
    Chan, Francis K. L.
    Ng, Siew C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (08) : 1266 - 1280
  • [47] Animal models of inflammatory bowel disease: a review
    Goyal, Nidhi
    Rana, Ajay
    Ahlawat, Abhilasha
    Bijjem, Krishna Reddy V.
    Kumar, Puneet
    INFLAMMOPHARMACOLOGY, 2014, 22 (04) : 219 - 233
  • [48] INFLAMMATORY BOWEL DISEASE IN AIRCREW: A SYSTEMATIC REVIEW
    Ioannides, N.
    Brown, R.
    Ioannides, S. J.
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 12 - 13
  • [49] Prevention in Inflammatory Bowel Disease: An Updated Review
    Long, Millie D.
    PRACTICAL GASTROENTEROLOGY, 2020, 44 (02) : 32 - 37
  • [50] Cannabinoids for Inflammatory Bowel Disease: A Scoping Review
    Brodaric, Alen
    Polikarpova, Aleksandra
    Hong, Jonathan
    CANNABIS AND CANNABINOID RESEARCH, 2025, 10 (01) : 18 - 27